Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Towards optimising the provision of laboratory services for bone turnover markers

Vasikaran SD, Chubb SA, Schneider HG

(2014), Pathology, 46(4), 267-73

Serum selenium status in Graves' disease with and without orbitopathy: a case-control study

Khong JJ, Goldstein RF, Sanders KM, Schneider H, Pope J, Burdon KP, Craig JE, Ebeling PR

(2014), Clin Endocrinol, 80(6), 905-10

"After-hours" staffing of trauma centres and outcomes among patients presenting with acute traumatic coagulopathy

Mitra B, Cameron PA, Fitzgerald MC, Bernard S, Moloney J, Varma D, Tran H, Keogh M

(2014), Med J Aust, 201(10), 588-91

Clinical population pharmacokinetics and toxicodynamics of linezolid

Boak LM, Rayner CR, Grayson ML, Paterson DL, Spelman D, Khumra S, Capitano B, Forrest A, Li J, Nation RL, Bulitta JB

(2014), Antimicrob Agents Chemother, 58(4), 2334-43

Detectable CD8 cells correlate with improved overall survival in adult B lymphoblastic leukaemia patients

Low M, Lee D, McLean C, Nguyen T, Morgan S, Grigoriadis G

(2014), Br J Haematol, 165(6), 883-5

Bacteraemia in ventricular assist devices: a common complication that need not affect clinical outcomes

Rosenfeldt FL, Kwa LJ, Porapakkham P, Rajadurai S, Jones K, van de Merwe J, Billah B, Porapakkham P, Esmore DS, Halvorsen DS, Aguirre VJ, Spelman DW

(2014), Heart Lung Circ, 23(3), 234-41

Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report

Cherk MH, Patil S, Beech P, Kalff V

(2014), J Med Case Rep, 8, 362

Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS

(2014), Leuk Lymphoma, 55(4), 920-8

Detection of hepatitis B virus DNA in serum is rare in the absence of hepatitis B surface antigen: impacts for detection and monitoring of chronic hepatitis B

Trevillyan JM, Dennison A, Jenney A, Spelman D

(2014), Pathology, 46(1), 69-71

Factor XIII assays

Opat S, Butler J, Malan E, Duncan E, Tran HA

(2013), In: Monagle P (ed), Haemostasis: Methods and Protocols, Methods in Molecular Biology, Volume 992, Humana Press, Springer, USA, Chapter 13, 171-80

Gentamicin and norfloxacin prophylaxis for transrectal ultrasound-guided prostate biopsy

Jeremiah, CJ, Spelman DW, Royce PL, Cheng AC

(2013), Healthcare Infect, 18(2), 67-71

Under-recognition of platelet dysfunction in myelodysplastic syndromes: are we only seeing the tip of the iceberg?

Burbury KL, Seymour JF, Dauer R, Westerman DA

(2013), Leuk Lymphoma, 54(1), 11-3

Challenges in performing surveillance for central line associated bacteraemia in haematology-oncology units

Worth LJ, Kennon J, Patil S, Cheng AC

(2013), Intern Med J, 43(4), 466-7

Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL

Sleebs BE, Kersten WJ, Kulasegaram S, Nikolakopoulos G, Hatzis E, Moss RM, Parisot JP, Yang H, Czabotar PE, Fairlie WD, Lee EF, Adams JM, Chen L, van Delft MF, Lowes KN, Wei A, Huang DC, Colman PM, Street IP, Baell JB, Watson K, Lessene G

(2013), J Med Chem, 56(13), 5514-40

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription

Thomas D, Powell JA, Vergez F, Segal DH, Nguyen NY, Baker A, Teh TC, Barry EF, Sarry JE, Lee EM, Nero TL, Jabbour AM, Pomilio G, Green BD, Manenti S, Glaser SP, Parker MW, Lopez AF, Ekert PG, Lock RB, Huang DC, Nilsson SK, Récher C, Wei AH, Guthridge MA

(2013), Blood, 122(5), 738-48

Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy

Ling V, Burnett AK, Bradstock K, Seymour JF, Hills RK, Wei A

(2013), Br J Haematol, 160(6), 861-3

Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival

Diakiw SM, Perugini M, Kok CH, Engler GA, Cummings N, To LB, Wei AH, Lewis ID, Brown AL, D'Andrea RJ

(2013), Br J Haematol, 161(6), 884-8

Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival

Thomas D, Powell JA, Green BD, Barry EF, Ma Y, Woodcock J, Fitter S, Zannettino AC, Pitson SM, Hughes TP, Lopez AF, Shepherd PR, Wei AH, Ekert PG, Guthridge MA

(2013), PLoS Biol, 11(3), e1001515

Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia

Kantarjian HM, Martinelli G, Jabbour EJ, Quintás-Cardama A, Ando K, Bay JO, Wei A, Gröpper S, Papayannidis C, Owen K, Pike L, Schmitt N, Stockman PK, Giagounidis A; SPARK-AML1 Investigators

(2013), Cancer, 19(14), 2611-9

Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma

Smeets MF, Chan AC, Dagger S, Bradley CK, Wei A, Izon DJ

(2013), PLoS One, 8(5), e62346

15 16 17 18 19